Clinical trials
Real World Data clinical trials
Below are recruiting real world data clinical trials, each written for real people, not researchers. We’re tracking 129 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06566170Recruiting
Donanemab for early Alzheimer's: a real-world study
This study compares donanemab plus usual care to usual care alone for people with early Alzheimer's symptoms, to see how well donanemab works in everyday life. You may be able to join if you have early memory or thinking problems and have a brain scan or blood test showing Alzheimer's-related changes.
Huntsville, AlabamaAges 60 years+ - NCT07109375Recruiting
Long-term study of pegunigalsidase alfa for Fabry disease
This study observes how well the medication pegunigalsidase alfa works over a long period in people with Fabry disease. It helps doctors learn more about managing the condition in everyday life.
ArezzoAges 18 years+ - NCT06716801Recruiting
How cenobamate works as early add-on treatment for epilepsy
This study looks at how well cenobamate works when added to other seizure medications for adults with focal epilepsy. It uses real-world data from medical records to see how people respond to treatment.
Paris, FranceAges 18 years+ - NCT06727227Recruiting
Study of Enhertu for HER2-low breast cancer
This study looks at how well the drug Enhertu works for patients with HER2-low breast cancer that has spread. If you are already planning to start Enhertu, researchers will collect data from your regular care to learn more about its effectiveness.
Panagyurishte, PazardzhikAges 18 years+ - NCT06753981Recruiting
Triple drug therapy for new PAH patients
This trial tests whether a combination of three medications works well and is safe for people newly diagnosed with pulmonary arterial hypertension (PAH) that is not low-risk. It aims to see if starting with triple therapy early can improve outcomes.
Jinan, ShandongAges 18–80 - NCT06794827Recruiting
Early access avacopan for ANCA vasculitis
This study looks at how well the drug avacopan works for people with a rare blood vessel disease called ANCA-associated vasculitis. It aims to help patients who are starting this treatment by tracking real-world results.
LeidenAges 16 years+ - NCT06808685Recruiting
Study of Elovie for advanced colorectal cancer
This study looks at how well a biosimilar version of bevacizumab (Elovie) works in people with advanced colorectal cancer that has spread and cannot be surgically removed. It aims to see if Elovie is safe and effective when used as the first treatment for this cancer.
Vitória, Espírito SantoAges 18 years+ - NCT06846229Recruiting
AI-assisted hospital decision-making study
This study tests whether an artificial intelligence (AI) tool can help doctors make better decisions by using your electronic health record data. If you are a patient in the hospital, your data may be used to improve care for future patients.
Wenzhou, ZhejiangAges Any age - NCT06953349Recruiting
Surgery systems with cataract and glaucoma treatment
This trial looks at how well certain surgical systems work when combined with cataract surgery and a glaucoma procedure. It may help people with glaucoma who need fewer medications after surgery.
Mesa, ArizonaAges 18 years+ - NCT07024680Recruiting
Sunitinib or sorafenib for papillary kidney cancer
This study looks at how well sunitinib or sorafenib work as a first treatment for a type of kidney cancer called papillary renal cell carcinoma (PRCC) that cannot be removed with surgery or has spread. It aims to understand real-world results in Chinese patients.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07039604Recruiting
Real-world study of PADN for pulmonary artery hypertension
This study tracks how well a procedure called PADN works for people with pulmonary artery hypertension (PAH) in real-life medical settings. PADN is a minimally invasive treatment that targets nerves around the lungs to help lower blood pressure in the arteries.
Nanjing, JiangsuAges Any age - NCT07052396Recruiting
Dupilumab for COPD: long-term real-world study
This study looks at how well dupilumab works over time for people with COPD who still have symptoms despite standard treatments and who have a certain type of inflammation (elevated eosinophils). It uses data from regular doctor visits and patient questionnaires to understand real-world benefits and safety.
AuerbachAges 18 years+ - NCT07073755Recruiting
Study of next treatments after targeted therapy resistance for advanced breast cancer
This study looks at what happens when people with advanced breast cancer switch to a new treatment after their cancer becomes resistant to targeted therapies like CDK4/6 inhibitors, PIK3CA inhibitors, or T-DXd. Researchers want to understand which next treatments work best in real life.
Changsha, HunanAges 18 years+ - NCT07102368Recruiting
Study of guselkumab for inflammatory bowel disease in Germany
This study tracks how well guselkumab (Tremfya) works in real-life for people with inflammatory bowel disease in Germany. If you are starting this treatment, researchers will watch your progress and ask you to fill out simple surveys about your symptoms.
BerlinAges 18 years+ - NCT07131163Recruiting
Study of lung cancer patients who got chemo-immunotherapy before planned surgery but didn't have surgery
This study looks at patients with stage II or III non-small cell lung cancer who started chemotherapy plus immunotherapy before planned surgery but did not actually have surgery. It aims to understand why surgery was canceled and how patients did over time.
Ramat GanAges 18 years+ - NCT07206628Recruiting
Eye drop use study for glaucoma patients
This study looks at how well patients with open-angle glaucoma follow their eye drop treatment using a special bottle called EASYGRIP®. It aims to understand if the bottle helps patients stick to their medication schedule.
BariAges 18 years+ - NCT07211126Recruiting
Control-IQ Study: Quality of Life with Type 1 Diabetes in France
This real-world study looks at how the Control-IQ system (an automated insulin pump with a continuous glucose monitor) affects blood sugar control and quality of life for people with type 1 diabetes in France. If you join, you will use the system as usual and fill out some questionnaires for one year.
AgenAges 6 years+ - NCT07235462Recruiting
Acoramidis for heart disease due to TTR amyloidosis
This study follows people with a heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM) who are starting treatment with acoramidis. It aims to see how well the medicine works in everyday medical practice.
HeidelbergAges 18 years+ - NCT07242248Recruiting
Real-world study of guselkumab for Crohn's and colitis
This study looks at how well guselkumab works in real life for people with moderate-to-severe Crohn's disease or ulcerative colitis. It tracks patients in the UK who start guselkumab as part of their normal care.
HarrowAges 18 years+ - NCT07127978Recruiting
Study of Givinostat in people with Duchenne muscular dystrophy
This study is for people with Duchenne muscular dystrophy (DMD) who are taking Givinostat, a daily oral medicine. Researchers will look at real-world data to see how the medicine works in everyday life, including lab results and how it's being used.
Little Rock, ArkansasAges 6 years+ - NCT07541261Recruiting
Real-World Study of Guselkumab for Ulcerative Colitis and Crohn's Disease
This study tracks how guselkumab (a biologic medication that reduces inflammation) works in patients with moderate-to-severe ulcerative colitis or Crohn's disease in Saudi Arabia. Researchers want to understand how the medication helps patients in everyday clinical practice, not in a controlled research setting.
JeddahAges 18 years+ - NCT07317102Recruiting
Omnipod 5 study in France: real-world results
This study is testing how well the Omnipod 5 insulin pump works in everyday life for people with type 1 diabetes. It's for people who are just starting to use this pump, so doctors can see how it helps manage blood sugar in real-world settings.
AngersAges 2 years+ - NCT07251868Recruiting
Study of SG in breast cancer with brain metastases
This study follows patients with breast cancer that has spread to the brain and who have already received the drug Sacituzumab Govitecan (SG). The goal is to learn how well SG works in real-world settings and to see how patients are doing over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07261826Recruiting
Long-term effects of fecal microbiota transplant
This study looks at how well fecal microbiota transplantation (FMT) works over time and checks its safety. If you have received at least one FMT for a qualifying condition, you may be able to participate.
Shanghai, Shanghai MunicipalityAges 3 years+
Hear when a new Real World Data trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for real world data?
- Yes. Clin2 currently lists 129 recruiting real world data studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a real world data trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a real world data trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.